When the kidneys fail — when they can no longer filter waste products and excess fluid adequately to sustain life — there are four treatment options: hemodialysis, peritoneal dialysis, kidney transplant, and conservative kidney management (choosing to manage symptoms without dialysis or transplant). Each of these options has a meaningfully different impact on daily life, medical outcomes, longevity, and quality of life, and the choice between them is one of the most consequential decisions a person with kidney failure and their family will make. Yet many patients arrive at kidney failure without having had a thorough, balanced discussion of all four options — often because their care team defaulted to in-center hemodialysis without explaining alternatives, or because the urgency of an acute presentation left no time for unhurried decision-making. This guide provides a clear, comparative overview of all kidney failure treatment options to support informed decision-making. For detailed information on each option, see the dedicated guides: hemodialysis explained, peritoneal dialysis explained, kidney transplant guide, and dialysis overview.
Kidney Transplant: The Best Option for Most Eligible Patients
Kidney transplant is the preferred treatment for kidney failure in most patients who are medically eligible — offering better survival, better quality of life, and more freedom than any form of dialysis. A successful kidney transplant restores near-normal kidney function 24 hours a day: the transplanted kidney filters waste, manages fluid balance, and produces hormones (erythropoietin, activated vitamin D, renin) that dialysis cannot replace. Transplant recipients typically have no dietary restrictions beyond a generally healthy diet, can live without a fixed treatment schedule, work and travel freely, and — especially those transplanted preemptively or early — have survival outcomes substantially better than dialysis patients of comparable health status. Living donor transplant is the gold standard: a kidney from a living, healthy, compatible donor can be scheduled electively — often before dialysis is ever needed — functions immediately, and lasts longer than a deceased donor kidney. Any adult who is healthy enough to donate (assessed through comprehensive evaluation) can give — relatives, friends, or even strangers through non-directed or paired exchange programs. Deceased donor transplant comes from donors who have died; patients are placed on a national waiting list and may wait months to years depending on blood type, sensitization, and geography. Both living and deceased donor kidneys require lifelong immunosuppression to prevent rejection. Not everyone is a transplant candidate — age, significant cardiovascular disease, active cancer, or inability to adhere to immunosuppression may preclude transplant — but most people with kidney failure should at least have a transplant evaluation to determine eligibility. The NIDDK provides treatment option summaries at the NIDDK kidney failure treatment choices page.
Hemodialysis: In-Center and Home Options
Hemodialysis (HD) removes waste and excess fluid by circulating blood through an external dialyzer (artificial kidney) three or more times per week. It is the most common form of kidney replacement therapy worldwide, accounting for approximately 70% of dialysis patients in the United States. In-center hemodialysis is performed at a dialysis clinic three times per week, each session 3.5–4 hours, with trained staff managing all technical aspects. It is appropriate for patients who prefer a structured clinical environment, cannot manage home therapy independently, lack adequate home support, or simply choose center-based care. The major constraints are the fixed three-weekly schedule (which limits work, travel, and spontaneity), the post-dialysis fatigue many patients experience after sessions, and the dietary and fluid restrictions required because dialysis only occurs three times per week. Home hemodialysis — performed daily or nocturnally using a home-compatible machine — provides better clearance (higher dialysis dose), better blood pressure control, less fatigue, fewer dietary restrictions, and better quality of life than conventional in-center HD. Home HD requires training (3–6 weeks), a suitable home environment, and typically a care partner for some programs. Most patients who try home HD prefer it; the major barrier is awareness — many patients are not offered or fully educated about the home HD option. Outcomes: conventional in-center HD is associated with higher mortality rates than transplant, but provides adequate life-prolonging therapy for most patients who are not transplant candidates. Survival on dialysis is highly variable and depends heavily on age, cardiovascular status, and comorbidities: a 25-year-old on dialysis has a very different prognosis than a 75-year-old. The KDIGO clinical practice guidelines cover HD management at the KDIGO CKD guidelines page.
Peritoneal Dialysis: Home-Based Continuous Treatment
Peritoneal dialysis (PD) uses the peritoneal membrane — the natural lining of the abdominal cavity — as a filter: dialysate solution instilled through a permanent catheter removes waste by diffusion and excess fluid by osmosis. PD is performed at home — either manually throughout the day (CAPD, 3–5 exchanges daily requiring no machine) or automatically overnight by a cycler machine (APD, 8–10 hour overnight treatment, daytime free). Advantages over in-center HD: peritoneal dialysis provides continuous or near-continuous clearance, which means fewer dietary restrictions (potassium is usually not restricted, fluid restriction is less strict), better preservation of residual kidney function, more stable blood pressure, no fixed center schedule, and for APD patients, completely free daytime hours. Most peritoneal dialysis patients live essentially normal daily lives, and many work full-time. PD is particularly advantageous for patients in remote areas (no need to travel to a center), those with cardiovascular instability (continuous vs intermittent removal), children, and those who want maximum schedule flexibility. Limitations: PD requires sterile technique and discipline in daily practice; the primary serious complication — peritonitis (infection of the peritoneal cavity, presenting as cloudy effluent and abdominal pain) — requires prompt treatment and is the leading cause of PD technique failure. Most patients can perform PD successfully with adequate training; those with major prior abdominal surgery, large hernias, or cognitive/physical limitations may not be suitable. PD is often underutilized relative to its potential benefit — many patients who would do well on PD are never offered it as an equal option. The NKF resources on PD are at the NKF kidney health page.
Conservative Kidney Management: Choosing Quality of Life Without Dialysis
Conservative kidney management (CKM) — also called conservative care or maximum supportive care — is the fourth option for kidney failure: managing symptoms, slowing progression, and maximizing quality of life without initiating dialysis or pursuing transplant. This option is rarely discussed explicitly with patients, yet it is a legitimate and sometimes the most appropriate choice — particularly for elderly patients with multiple serious comorbidities for whom the burdens of dialysis may outweigh the benefits in terms of life quality and longevity. Who may benefit from conservative management: the survival benefit of dialysis over conservative management is largest in younger patients without major comorbidities and smallest — or even absent — in elderly patients (particularly those over 75–80) with multiple serious conditions including severe cardiovascular disease, advanced dementia, frailty, or cancer. Studies comparing elderly frail patients who chose dialysis versus CKM found that dialysis did not clearly extend life in this group, and many spent a substantial proportion of their remaining time on dialysis or recovering from dialysis-related complications rather than living at home. For these patients, CKM focuses on symptom management (managing fluid overload, itching, pain, fatigue, and nausea), dietary optimization, careful medication management, and access to palliative care and hospice support as symptoms progress. What conservative management involves: ongoing nephrology and primary care follow-up to manage blood pressure, anemia, phosphorus, and symptoms; dietary support from a renal dietitian; social work and psychological support; and palliative care consultation when appropriate. Patients who choose CKM are not “giving up” — they are making a values-based decision that prioritizes living as fully as possible on their own terms rather than extending life through a treatment with significant burden. This decision is fully reversible — patients who choose CKM initially can reconsider and pursue dialysis or transplant evaluation at any time. The importance of advance care planning: all patients approaching kidney failure — regardless of which treatment option they choose — benefit from advance care planning: documenting their preferences for life-sustaining treatment, completing healthcare directives, identifying a healthcare proxy, and discussing their values and goals with family and their medical team. These documents ensure that patients’ wishes guide care in the event they cannot speak for themselves. For patients who want to understand all their options and prepare targeted questions, the questions to ask guide covers the most important conversations to have with the nephrologist, and the preparing for dialysis guide covers preparation for those who choose dialysis. The StatPearls kidney disease management reference is at the StatPearls resource.
Sources: NIDDK Choosing a Treatment · KDIGO CKD Guidelines · National Kidney Foundation · StatPearls: Nephrology
Comparing Treatment Options: Survival, Quality of Life, and Daily Impact
Understanding how the four kidney failure treatment options compare — in terms of survival, quality of life, and daily life impact — helps patients make a choice that aligns with their values and circumstances. These comparisons are based on the best available evidence, but it’s important to acknowledge that most of the comparison data comes from observational studies, not randomized controlled trials (which are largely infeasible in this population), and that selection bias — healthier patients choosing transplant or home therapy — affects all comparative estimates. Survival comparison: kidney transplant is associated with the best survival outcomes of any treatment. Studies comparing waitlisted dialysis patients (who have been evaluated and approved for transplant) with transplanted patients of similar health status show approximately 40–60% lower mortality in transplant recipients. Living donor preemptive transplant (before dialysis) is associated with the best outcomes of all. Peritoneal dialysis and home hemodialysis are associated with better survival than in-center hemodialysis in many observational studies, likely reflecting both selection effects (healthier patients choosing home therapy) and genuine treatment benefits (better hemodynamics, better residual kidney function preservation, better blood pressure control). Conservative management is associated with shorter median survival than dialysis in most populations, though in elderly frail patients with multiple comorbidities the survival difference may be small and the quality of life difference large. Quality of life comparison: kidney transplant recipients consistently report the highest quality of life across virtually all measured domains — physical functioning, vitality, emotional wellbeing, social functioning, and role functioning — compared to dialysis patients. Home dialysis patients report better quality of life than in-center HD patients, particularly in terms of schedule flexibility, sense of autonomy, and fewer post-treatment fatigue episodes. In-center HD patients typically rate their quality of life as significantly below population norms, primarily due to fatigue, dietary restrictions, and the burden of the fixed three-weekly schedule. Conservative management patients who elect this approach typically report good quality of life relative to their comorbidity burden, particularly when managed with active symptom control, though this depends heavily on access to palliative care support. Daily life impact: transplant recipients live the most normal daily life — no fixed treatment schedule, no dietary dialysis restrictions, ability to work and travel freely, no machine or catheter maintenance. Home APD patients have free daytime hours and treat overnight; CAPD patients integrate exchanges into their day but remain free of center visits. In-center HD structures three days per week around the dialysis schedule, impacting work, travel, and spontaneity. Conservative management patients may experience progressive symptoms as kidney function declines but are free of treatment burdens. Making the decision: the best treatment option is not the same for every patient. Age, comorbidities, living situation, work and family responsibilities, personal values, and the availability of a living donor all influence which option is most appropriate. The most important principle is that patients should make this decision with full information about all options — not just the default option offered by the first provider they see. The StatPearls nephrology reference covers treatment modality evidence at the StatPearls resource.
How to Choose: Key Questions to Guide Your Decision
Choosing among kidney failure treatment options is deeply personal, and no single set of criteria applies universally. The following key questions help patients and their families organize their thinking and prioritize what matters most. Am I eligible for transplant? This is the first and most important question, because transplant is the best option for most eligible patients. If there has been no transplant evaluation, requesting a referral to a transplant center is the immediate priority regardless of other decisions. Not knowing you’re eligible is not a reason to stay on dialysis. Do I have a potential living donor? A living donor dramatically improves transplant outcomes and eliminates the waiting period. Any family member, friend, or altruistic stranger can volunteer to be evaluated. If a potential donor exists, pursuing their evaluation simultaneously with the recipient evaluation should be a top priority. How important is schedule flexibility vs structured support? Patients who value maximum schedule flexibility, work full-time, want to travel, or have young children will generally do better on home therapy (peritoneal dialysis or home hemodialysis). Patients who prefer a structured clinical environment, are not comfortable managing their own care, or lack home support may do better with in-center HD. What is my living situation and home environment? Home dialysis requires adequate space, water supply, power, and a sufficiently clean environment; assessment by a home therapy nurse determines suitability. Patients in unsuitable home environments may not be candidates for home therapy until changes are made. What are my most important health goals? For patients whose primary goal is maximum longevity, transplant is the strongest option. For patients whose primary goal is maintaining their daily independence and lifestyle, home dialysis options provide more freedom than in-center HD. For elderly patients with multiple serious comorbidities who prioritize comfort and quality of remaining life over length, conservative management merits serious consideration. Have I spoken with current patients on each modality? Peer perspectives from people living with each treatment option are among the most valuable sources of practical information. Most transplant centers and dialysis units can connect prospective patients with peer mentors. The NKF also facilitates patient-to-patient connections through their peer mentoring programs. For a complete list of the specific questions to ask the nephrologist and transplant team about each option, see the questions to ask about dialysis or transplant guide. The preparing for dialysis guide covers preparation for those who choose hemodialysis or peritoneal dialysis. Patients exploring living donation should see the living kidney donation guide.
Starting the Conversation With Your Nephrologist
Many patients arrive at late-stage chronic kidney disease (CKD stage 4 or 5) without having had a frank, comprehensive conversation about all available treatment options. This is a known, documented problem in nephrology care: studies consistently find that a significant proportion of patients who end up on in-center hemodialysis were never offered a choice — they started dialysis urgently or defaulted to the most visible option without understanding that home dialysis, transplant, and conservative management were equally available and potentially better suited to their situation. If you have not yet had a detailed, unhurried conversation about all four treatment options with your nephrologist, requesting that conversation is the single most important step you can take. Ideally, this conversation happens well before dialysis is needed — at CKD stage 4 (eGFR 15–29 mL/min), when there is time to evaluate transplant eligibility, pursue a living donor evaluation, and train for home dialysis if desired. Starting this conversation at CKD stage 3 is even better. Patients who receive timely pre-dialysis education choose home therapy more often, have better access outcomes (planned start rather than emergency catheter), and experience less anxiety about treatment. If you want to go into that conversation fully prepared, the questions to ask about dialysis or transplant guide lists the most important questions to bring to the nephrologist, transplant team, and dialysis program. The kidney transplant process starts with an evaluation — the kidney transplant evaluation guide explains exactly what to expect at each stage. Beginning with accurate, complete information is what makes truly informed consent possible — and what the research consistently shows leads to better outcomes and greater patient satisfaction with their treatment course. The NIDDK patient education resources are at the NIDDK kidney disease page.
Insurance, Access, and Practical Barriers to Treatment Choice
Beyond clinical suitability, practical and logistical factors significantly shape which treatment options are realistically accessible for a given patient. Insurance coverage: in the United States, Medicare covers dialysis and kidney transplant for most patients with end-stage renal disease (ESRD) regardless of age, through the ESRD program established in 1972. This coverage includes dialysis treatments, transplant surgery, immunosuppressive medications (with some time limits), and related care. Medicaid, private insurance, and the Veterans Affairs (VA) system cover kidney failure treatment for their respective populations. The 2021 Immunosuppression for Kidney Transplant Act extended Medicare coverage of immunosuppressive medications beyond the original 36-month limit — a significant change that removed a prior financial barrier to long-term transplant maintenance. Patients should confirm the specific coverage terms with their insurer before making treatment decisions, as cost-sharing, prior authorization requirements, and drug formulary status vary. Geographic access: in-center hemodialysis requires proximity to a dialysis center, which limits the option for patients in rural areas who may face long round-trip commutes multiple times per week. Home dialysis — peritoneal dialysis or home hemodialysis — eliminates this geographic barrier. Transplant evaluation and surgery require access to a transplant center, which may be at some distance; however, the evaluation is conducted over time and most transplant centers have remote consultation options. Social support: home hemodialysis benefits from — and some programs require — a trained care partner who can assist in emergencies. Patients who live alone should discuss this with the home HD team; some programs have protocols for independent home HD. Peritoneal dialysis is more commonly done solo. The life on dialysis guide covers the day-to-day realities that affect long-term treatment satisfaction, including how patients across modalities manage work, family life, and travel.
Summary: kidney failure is not a single pathway — it is a fork with four meaningful branches, each with distinct outcomes, daily life implications, and eligibility criteria. Transplant is the strongest option for most eligible patients and should always be evaluated. Home dialysis — peritoneal or home hemodialysis — offers better quality of life than in-center HD and is underutilized relative to its potential. In-center HD is a well-established, effective therapy for patients who prefer or require the structure and clinical support of a center setting. Conservative management is a legitimate, values-aligned choice for patients for whom the burdens of dialysis outweigh its benefits. No single option is right for every patient, and the most important thing is that patients arrive at their decision with accurate, complete information about all four paths — not just the path of least resistance.
My nephrologist told me I’d need dialysis within the next year and I honestly didn’t know there were so many options. I assumed it just meant going to a center three times a week. Reading this article made me realize I should ask specifically about peritoneal dialysis and whether I’d be a candidate — I work from home so the APD overnight option sounds like it might fit my schedule much better than in-center HD. I had no idea home options even existed until I found this.
The section on conservative management is important and not discussed enough. My father was 82 with advanced heart failure when he was told his kidneys were failing. His cardiologist said dialysis was unlikely to extend his life meaningfully given his overall condition. He chose conservative management, was connected to a palliative care team, and spent his last eight months at home with his family — not in a dialysis center three times a week. That was absolutely the right decision for him. Thank you for presenting this as a legitimate option without judgment.
Diana, asking your nephrologist about peritoneal dialysis and home hemodialysis options is exactly the right first step — both of those questions are reasonable to bring up at the next appointment, and the team can assess your suitability and walk you through what training and setup would involve. The fact that you work from home is a genuine practical advantage for home therapy. James, thank you for sharing your father’s experience. The decision your father and his family made was thoughtful and medically appropriate for his situation — and the fact that he was able to spend that time at home with his family is exactly what conservative management, done well with good palliative care support, is meant to allow. Not every patient is in that situation, but for those who are, having that option clearly presented and supported makes an enormous difference.